top of page

Eduovisual

Multisystem Processes & Disorders

Septic arthritis: diagnosis and management

Clinical Overview and When to Suspect Septic Arthritis

— Incidence ~2–10/100,000/year; rises to 30–70/100,000 in patients with rheumatoid arthritis (RA) or prosthetic joints.

Knee is involved in ~50% of native joint cases; hip more common in children; sternoclavicular/sacroiliac joints suggest IV drug use.

— Hematogenous seeding (most common in adults) > contiguous spread (cellulitis, osteomyelitis) > direct inoculation (injection, surgery, trauma, bite).

— Synovium is highly vascular and lacks a basement membrane, making it vulnerable to bloodstream pathogens.

— Acute (<2 weeks) monoarticular hot, swollen, painful joint with restricted active and passive ROM.

— Fever in only ~50%; absence of fever does not rule out septic arthritis.

— Underlying joint disease (RA, OA, gout, prior surgery) — pre-existing damage is the single strongest risk factor.

— Bacteremia source: endocarditis, UTI, pneumonia, skin/soft tissue infection, indwelling lines.

Step 3 management: Any acutely inflamed joint in an adult is septic until proven otherwise — the correct first move in both clinic and ED is urgent arthrocentesis before antibiotics, unless the patient is in septic shock requiring empiric coverage first.

Board pearl: A "flare" of gout or RA in a single joint with fever should still trigger tap — crystals and infection coexist in ~5% of cases.

Definition: Bacterial (or rarely fungal/mycobacterial) infection of a joint space, producing rapid cartilage destruction via neutrophil-mediated proteolysis within 24–48 hours of bacterial seeding.
Epidemiology:
Pathogenesis:
When to suspect on the wards or in clinic:
High-risk hosts: age >80, diabetes, RA on biologics, cirrhosis, ESRD/dialysis, HIV, IV drug use, recent intra-articular injection, prosthetic joint, sickle cell disease (think Salmonella).
Why it matters for Step 3: Delay in arthrocentesis by even 24–48 hours dramatically increases mortality (up to 10–15%) and rates of permanent joint dysfunction (~40%).
Solid White Background
Presentation Patterns and Key History

— 1–2 week history of progressive monoarticular pain, warmth, swelling, and inability to bear weight or move the joint.

— Fever, rigors, malaise; in elderly or immunocompromised, may present only as confusion or failure to thrive.

— Young, sexually active adult; triad of migratory polyarthralgia, tenosynovitis (wrist/ankle/fingers), and pustular/vesicular skin lesions on extremities.

— May progress to true purulent monoarthritis of knee/wrist; ask about new partners, dysuria, urethral/vaginal discharge.

— RA patients, immunosuppressed, or those with overwhelming sepsis/endocarditis — S. aureus most common.

— Mortality up to 30% — a red flag for occult endocarditis; get blood cultures and TTE.

— Early (<3 months): virulent organisms (S. aureus, GNRs).

— Delayed (3–24 months): indolent — coagulase-negative staph, Cutibacterium acnes (shoulder).

— Late (>24 months): hematogenous seeding.

— Recent dental work, GU instrumentation, IV drug use, tick exposure (Lyme), unpasteurized dairy (Brucella), TB exposure, cat/dog bite (Pasteurella), rose thorn (Sporothrix), saltwater (Vibrio), freshwater (Aeromonas).

— Sexual history for gonococcus; travel history for endemic mycoses.

— Immunosuppressants, recent intra-articular injection (steroid, hyaluronate).

Key distinction: Migratory polyarthralgia + tenosynovitis + pustules = gonococcal; abrupt monoarticular knee with fever and no skin findings = non-gonococcal (S. aureus). These two phenotypes drive different empiric antibiotic choices.

Board pearl: Lyme arthritis presents as intermittent, large-joint (knee) effusion with surprisingly preserved function — a key contrast to true pyogenic septic arthritis.

Classic acute bacterial septic arthritis:
Gonococcal arthritis (disseminated gonococcal infection, DGI):
Polyarticular septic arthritis (10–20%):
Prosthetic joint infection (PJI):
Targeted history questions:
Solid White Background
Physical Exam Findings and Hemodynamic Assessment

— Erythema, swelling, joint held in position of maximal capsular volume (knee in slight flexion, hip in flexion/abduction/external rotation, shoulder adducted/internally rotated).

— Look for portals of entry: skin breaks, cellulitis, puncture wounds, surgical scars, IVDU track marks.

— Pustular or vesiculopustular skin lesions on distal extremities → think DGI.

— Warmth and tenderness over the joint line (not just periarticular).

Severe pain with minimal passive ROM is the most specific bedside finding; periarticular processes (bursitis, cellulitis) allow gentle passive ROM.

— Effusion: ballottement of patella, fluctuance.

— Hip: log-roll test — pain with internal/external rotation in supine; child may refuse to walk.

— Sacroiliac: FABER, direct SI tenderness; consider in IVDU with buttock/back pain and fever.

— Sternoclavicular: localized swelling/erythema over SC joint in IVDU — get CT to rule out mediastinal extension.

— Vital signs: tachycardia, fever, hypotension → screen for sepsis using qSOFA/SIRS.

— Cardiac: new murmur (endocarditis), especially with polyarticular disease or S. aureus bacteremia.

— Skin: Janeway lesions, Osler nodes, splinter hemorrhages, IVDU stigmata.

— Lymphadenopathy, hepatosplenomegaly.

— MAP <65, lactate >2, AMS, or oliguria triggers sepsis bundle: fluids 30 mL/kg, blood cultures ×2, broad-spectrum antibiotics within 1 hour, source control via arthrocentesis.

CCS pearl: On CCS, after focused MSK exam, immediately order vitals q1h, blood cultures ×2, CBC, CMP, lactate, ESR/CRP, peripheral IV, NPO, then move the clock forward to arthrocentesis — do not start antibiotics before tap unless hemodynamically unstable.

Board pearl: A child refusing to bear weight with fever and hip held in flexion-abduction-ER → septic hip until imaging and arthrocentesis prove otherwise.

Inspection:
Palpation and ROM:
Joint-specific maneuvers:
Systemic exam:
Hemodynamic assessment:
Solid White Background
Diagnostic Workup — Initial Labs, Imaging, and Biomarkers

— Aspirate as much fluid as possible; send for:

Cell count with differential

Gram stain and culture (aerobic + anaerobic)

Crystal analysis (polarized microscopy)

— Glucose, protein, lactate (lower yield)

— If gonococcal suspected: also send urethral/cervical/pharyngeal/rectal NAAT.

WBC >50,000/μL with >75% PMNs → highly suspicious for septic arthritis (sensitivity ~60%, specificity ~85%).

— WBC 2,000–50,000 → inflammatory (gout, RA, reactive); still tap and culture.

Prosthetic joints: lower threshold — WBC >1,100 with >64% PMNs is suggestive after >6 weeks postop.

— Gram stain positive in only 30–50% — a negative Gram stain does not exclude septic arthritis.

— Culture is gold standard; gonococcus grows poorly — only ~50% positive synovial cultures.

— CBC: leukocytosis (~50% sensitive).

ESR and CRP: elevated in >90%; CRP trends faster for monitoring response.

Procalcitonin elevated supports bacterial etiology but is not diagnostic alone.

— Blood cultures ×2 before antibiotics — positive in 25–50% of non-gonococcal cases; rule out concurrent bacteremia/endocarditis.

— Lactate, BMP, LFTs for sepsis workup and antibiotic dosing.

— Uric acid: poor discriminator; don't rely on it.

Plain radiographs of joint: baseline for soft tissue swelling, effusion, osteomyelitis, gas, chondrocalcinosis — usually unrevealing early.

Ultrasound: confirms effusion, guides aspiration of hip/shoulder.

MRI: most sensitive — detects osteomyelitis, abscess, especially for SI joint, sternoclavicular, spine.

Board pearl: Synovial lactate >10 mmol/L is highly specific for septic arthritis but not yet a standard order — Gram stain + culture + cell count remain the diagnostic triad.

Step 3 management: Do not delay arthrocentesis for imaging in an accessible joint like the knee.

Arthrocentesis is the single most important test — perform before antibiotics whenever possible (ideally within hours).
Synovial fluid interpretation:
Serum labs:
Imaging:
Solid White Background
Diagnostic Workup — Advanced and Confirmatory Studies

— Indicated if persistent fever, worsening effusion, or rising inflammatory markers despite 48–72 h of appropriate antibiotics — assess for need for surgical drainage.

— Compare cell counts; drop in WBC and PMN% supports response.

MRI with contrast — gold standard for axial joints (SI, sternoclavicular, spine, hip) and to rule out adjacent osteomyelitis (which extends antibiotic course from ~2 to ≥6 weeks).

CT — useful for sternoclavicular joint (mediastinal extension), prevertebral abscess, or guiding aspiration of deep joints.

Three-phase bone scan / tagged WBC scan — when MRI contraindicated or for prosthetic joint workup.

PET/CT — emerging role for PJI evaluation.

Synovial fluid NAAT for N. gonorrhoeae, Borrelia burgdorferi, M. tuberculosis, Kingella kingae (children).

16S rRNA PCR of synovial fluid when cultures are negative but suspicion remains high (esp. after empiric antibiotics).

— Fungal cultures and mycobacterial AFB stain/culture for chronic monoarthritis or immunocompromised patients.

— Hold antibiotics ≥2 weeks before aspiration if clinically safe to maximize culture yield.

Alpha-defensin synovial assay — high sensitivity/specificity for PJI.

— Send multiple intraoperative tissue cultures (5–6 sites) plus sonication of explanted hardware.

Key distinction: Reactive arthritis (post-Chlamydia, Shigella, Salmonella, Yersinia, Campylobacter) has sterile synovial fluid with high WBC but negative Gram stain/culture and resolves with NSAIDs — do not treat with prolonged antibiotics.

Board pearl: Prosthetic shoulder with indolent pain and negative routine cultures → request prolonged anaerobic culture (14 days) for Cutibacterium acnes.

Repeat arthrocentesis:
Advanced imaging:
Molecular and special microbiology:
Prosthetic joint infection workup:
Endocarditis evaluation: TTE in all S. aureus bacteremia or polyarticular septic arthritis; TEE if TTE non-diagnostic and suspicion remains high.
Solid White Background
Risk Stratification and First-Line Management Logic

— Hemodynamics: septic shock vs. stable.

— Host: immunocompromised, prosthetic joint, IVDU, age >65.

— Joint: native peripheral vs. axial (hip, SI, SC) vs. prosthetic.

— Pathogen risk: MRSA prevalence locally, gonococcal exposure.

— Two large-bore IVs, IVF resuscitation if septic, continuous monitoring.

— Blood cultures ×2 → arthrocentesis → empiric IV antibiotics → orthopedic surgery consultation same day.

— Pain control with acetaminophen ± short-acting opioid; avoid NSAIDs initially if AKI or sepsis.

— NPO in case of OR.

— Native joint: serial closed-needle aspirations, arthroscopic washout, or open arthrotomy — choice depends on joint and surgeon preference.

— Hip and shoulder typically require operative drainage (deep, difficult to aspirate repeatedly).

— Knee — arthroscopic lavage usually preferred; serial aspirations acceptable if responding.

— Prosthetic joint: DAIR (debridement, antibiotics, implant retention) if acute (<3 weeks symptoms) and stable implant; otherwise 1- or 2-stage revision.

— Healthy, gram stain (+) cocci in clusters → MRSA coverage (vancomycin).

— Gram stain (+) cocci in chains → consider streptococci, continue vanc until speciated.

— Gram stain (-) rods → add antipseudomonal beta-lactam (cefepime/piperacillin-tazobactam).

— Sexually active adult with tenosynovitis/pustules → IV ceftriaxone.

— Negative Gram stain but high suspicion → cover broadly: vancomycin + ceftriaxone.

Step 3 management: Sequence in CCS = blood cultures → arthrocentesis → empiric IV antibiotics → orthopedic consult → admit. Skipping source control delays cure regardless of antibiotic choice.

CCS pearl: Move the clock 24–48 h; reassess fever curve, repeat CRP, examine joint, document trending improvement — if not improving, repeat tap and re-consult ortho for further drainage.

Risk-stratification anchors:
Immediate priorities (first 1–2 hours):
Source control is curative:
Decision logic for empiric coverage:
Solid White Background
Pharmacotherapy — Empiric and Targeted Antibiotic Regimens

Vancomycin 15–20 mg/kg IV q8–12h (trough 15–20 or AUC 400–600) — covers MRSA, MSSA, streptococci.

— Add ceftriaxone 2 g IV daily if gonococcal suspicion or gram-negative coverage needed.

— Use cefepime 2 g q8h or piperacillin-tazobactam 4.5 g q6–8h instead of ceftriaxone if immunocompromised, IVDU, or Pseudomonas risk.

— Penicillin allergy: aztreonam + vancomycin; verify allergy history.

MSSAnafcillin 2 g IV q4h or cefazolin 2 g IV q8h (preferred over vancomycin for MSSA — better outcomes).

MRSA → vancomycin; alternatives: daptomycin 6–8 mg/kg/day, linezolid, ceftaroline.

Streptococci → ceftriaxone or penicillin G.

Gonococcus → ceftriaxone 1 g IV/IM daily ×7 days + single-dose azithromycin/doxycycline for Chlamydia.

Pseudomonas → cefepime + tobramycin or ciprofloxacin, especially in IVDU.

Gram-negative enterics (E. coli, etc.) → ceftriaxone or ertapenem.

Lyme arthritis → oral doxycycline 100 mg BID ×28 days (not septic per se, but tested).

Anaerobes (bite wounds) → ampicillin-sulbactam.

— Native joint, gonococcal: 7–14 days total.

— Native joint, non-gonococcal: 2 weeks IV, then 2 weeks oral, total ~4 weeks (some 3–4 weeks IV depending on organism and response).

— With osteomyelitis: ≥6 weeks.

— Prosthetic joint with DAIR: 6 weeks IV + chronic oral suppression for many.

Board pearl: Cefazolin or nafcillin beats vancomycin for MSSA — switch promptly once susceptibilities return. Don't reflexively continue vancomycin.

Step 3 management: Always reconcile renal dosing for vancomycin/cefepime and arrange OPAT (outpatient parenteral antibiotic therapy) follow-up before discharge.

Empiric IV antibiotics (start after cultures):
Targeted therapy after culture:
Duration:
Oral step-down: when clinically improving, afebrile, declining CRP — options include linezolid, levofloxacin + rifampin (staph PJI), TMP-SMX.
Solid White Background
Procedures and Source Control — Drainage Strategy

Serial needle aspiration: acceptable for accessible joints (knee), repeat daily until effusion resolves; document declining cell counts.

Arthroscopic lavage: preferred for knee, shoulder, ankle; allows debridement and synovectomy; shorter hospital stay.

Open arthrotomy: hip (especially pediatric), loculated infections, failed arthroscopy, immunocompromised, or extensive joint destruction.

— 48–72 h after initial drainage and antibiotics: clinical exam, repeat CRP, repeat aspirate if effusion persists.

— Lack of improvement → repeat OR washout; do not just "wait it out."

DAIR (debridement, antibiotics, implant retention): symptoms <3 weeks, stable implant, susceptible organism, intact soft tissue. Exchange modular components (liner, head).

One-stage revision: select cases with known organism, good bone stock, no sinus tract.

Two-stage revision: gold standard for chronic PJI — explant + antibiotic spacer × 6 weeks IV abx → reimplant after markers normalize.

Resection arthroplasty / arthrodesis / amputation: salvage in failed multiple revisions.

— Continuous joint immobilization initially for pain, then early passive ROM by day 2–3 to prevent stiffness.

— Avoid weight-bearing on infected hip/knee until cleared.

— Physical therapy referral once infection controlled.

— Sternoclavicular: often requires resection if mediastinitis or abscess.

— Spine: surgical drainage if neurologic deficit, instability, or epidural abscess.

CCS pearl: On a CCS case, after arthrocentesis confirms septic arthritis, the next single most important order is "consult orthopedic surgery — urgent washout". Antibiotics and consult run in parallel.

Board pearl: Early ROM (within 48–72 h of source control) prevents adhesions and improves functional outcome — immobilization is for analgesia, not therapy.

Universal principle: Antibiotics alone do not cure septic arthritis — adequate drainage is mandatory.
Native joint drainage options:
Reassessment timeline:
Prosthetic joint infection (PJI) — surgical algorithms:
Adjuncts:
Special situations:
Solid White Background
Special Populations — Elderly and Renal/Hepatic Impairment

— Atypical presentation: low-grade fever, confusion, falls, anorexia; classic triad in <50%.

— Higher prevalence of underlying OA, RA, prosthetic joints, diabetes — all risk factors.

— Higher mortality (up to 15–20%) and worse functional recovery.

— Beware polypharmacy: anticoagulants complicate aspiration timing — hold/reverse if INR supratherapeutic or DOAC within 24–48 h, but do not delay tap in unstable patient (use ultrasound guidance, pressure dressing).

— Screen for occult bacteremia source: indwelling Foley, pressure ulcers, endocarditis.

— Renal dose vancomycin by AUC monitoring; trough levels q48–72h if CrCl <30.

Cefepime — reduce dose to avoid neurotoxicity (encephalopathy, myoclonus, NCSE) — especially in elderly with CKD.

— Avoid aminoglycosides when possible; if needed, single daily dose with levels.

— Daptomycin: dose q48h if CrCl <30; monitor CK weekly (myopathy).

— Dialysis patients have high S. aureus carriage → empiric vanc + cover GNRs.

— Linezolid: monitor for thrombocytopenia, lactic acidosis; limit to 28 days.

— Avoid tigecycline (mortality signal).

— Adjust clindamycin in severe hepatic dysfunction.

— Arthrocentesis is generally safe on therapeutic warfarin (INR <3.5) or DOACs per ACR/EULAR — bleeding risk low; do not withhold tap.

— Hold antiplatelets only if elective and clinically allows.

Step 3 management: In an elderly patient with prosthetic knee, AKI, and septic shock, choose vancomycin (AUC-dosed) + cefepime (renally dosed), get urgent ortho washout, and consult ID and pharmacy for OPAT planning.

Board pearl: Cefepime neurotoxicity in CKD presents as encephalopathy and myoclonus that resolves within 48–72 h of stopping the drug — a frequent test scenario.

Elderly (>65–80 years):
Chronic kidney disease / dialysis:
Hepatic impairment:
Anticoagulation considerations:
Solid White Background
Special Populations — Pregnancy, Pediatrics, and Other Subgroups

— Rare but high-stakes; gonococcal arthritis disproportionately affects pregnant patients due to immune modulation.

— Safe antibiotics: ceftriaxone, cefazolin, nafcillin, vancomycin, azithromycin.

— Avoid: doxycycline (after 2nd trimester teeth), fluoroquinolones, aminoglycosides (relative), TMP-SMX in 1st/3rd trimester.

— Imaging: MRI without gadolinium preferred; ultrasound is first-line for hip aspiration.

— Coordinate with OB; treat partners for STIs.

Kingella kingae in children 6 months–4 years — fastidious, grows in blood culture bottles; PCR of synovial fluid most sensitive.

S. aureus (including MRSA) most common overall; Salmonella in sickle cell disease.

Kocher criteria for septic hip vs. transient synovitis: fever >38.5°C, non-weight-bearing, ESR >40, WBC >12,000 — 4/4 → ~99% probability.

— Hip and shoulder — usually require operative drainage.

— Empiric: cefazolin or vancomycin (if MRSA risk) ± ceftriaxone.

— Duration: 2–4 weeks; early IV-to-oral switch is well-supported.

— Consider fungal (Candida, Cryptococcus), mycobacterial, atypical organisms.

— Tap and send AFB, fungal cultures, and broad bacterial.

Board pearl: A toddler refusing to walk, febrile, with hip held in flexion-abduction-ER → ultrasound of hip and urgent orthopedic aspiration/drainage in the OR, not the ED.

Key distinction: Transient synovitis = afebrile, ambulates, normal labs, resolves with NSAIDs; septic hip = the opposite — Kocher score guides decision-making.

Pregnancy:
Pediatrics:
Sickle cell disease: Empirically cover Salmonella and S. aureusceftriaxone + vancomycin.
IV drug use: Sternoclavicular, sacroiliac, spine joints; cover Pseudomonas and MRSA — vancomycin + cefepime.
HIV / immunocompromised:
Recent intra-articular injection (within 3 months): Coagulase-negative staph, S. aureus, Pseudomonas if multidose vial contamination.
Solid White Background
Complications and Adverse Outcomes

Cartilage destruction within 8 hours of bacterial inoculation — irreversible chondrolysis from PMN proteases.

— Osteomyelitis (contiguous spread) — extends antibiotic course to ≥6 weeks.

— Joint ankylosis, contracture, chronic instability.

— Avascular necrosis, especially femoral head in septic hip.

— Growth plate damage in pediatric hip → limb length discrepancy.

— Recurrent infection or chronic sinus tract (esp. prosthetic).

— Bacteremia → septic shock, multi-organ dysfunction.

Endocarditis in 5–10% of S. aureus septic arthritis — get TTE; TEE if persistent bacteremia.

— Metastatic abscesses (psoas, paraspinal, epidural, splenic).

— DVT/PE from immobility and inflammation.

— Toxic shock syndrome (rare).

— Native joint: 7–15%; rises with polyarticular disease, age, immunocompromise, S. aureus bacteremia.

— Polyarticular septic arthritis: up to 30%.

— PJI: 2–7%, with high reoperation/morbidity.

— ~40% with permanent joint dysfunction.

— Delay to drainage and inadequate source control are strongest predictors of poor outcome.

— Vancomycin nephrotoxicity (AKI in ~15%, especially with concurrent piperacillin-tazobactam or contrast).

C. difficile colitis with prolonged broad-spectrum antibiotics — clindamycin, fluoroquinolones, cephalosporins highest risk.

— Catheter-related bloodstream infection (CRBSI) from prolonged PICC for OPAT.

— Daptomycin myopathy; linezolid thrombocytopenia and serotonin syndrome.

Step 3 management: During OPAT, weekly CBC, CMP, CRP, and vancomycin trough/AUC are standard; document line site exam and re-evaluate need for continued IV access.

Board pearl: Persistent fever or rising CRP at 72 hours of appropriate antibiotics = inadequate source control — re-tap, re-image, re-operate. Don't blame the bug.

Local joint complications:
Systemic complications:
Mortality:
Functional outcomes:
Treatment-related adverse events:
Solid White Background
When to Escalate Care — ICU, Consult, and Inpatient Triage

Orthopedic surgery — same-day for drainage/washout.

Infectious disease — empiric and targeted regimen, OPAT planning, source workup.

Rheumatology — when crystal arthropathy or autoimmune flare coexists, or when diagnosis remains unclear.

Cardiology — if endocarditis suspected (new murmur, S. aureus bacteremia, polyarticular).

— Septic shock: MAP <65 despite 30 mL/kg IVF or lactate >4 → vasopressors, central line, ICU.

— Respiratory failure, AMS, severe AKI requiring CRRT.

— Bacteremia with hemodynamic instability awaiting source control in OR.

— Mediastinal extension from SC joint infection or epidural abscess with neurologic compromise.

— Hemodynamically stable, source controlled, on appropriate IV antibiotics with declining markers.

— Telemetry not routinely required unless endocarditis or sepsis-related arrhythmia.

— Afebrile ≥48 h, tolerating PO, declining CRP, definitive drainage achieved, oral or OPAT plan with reliable follow-up, pain controlled.

— Functional status sufficient for safe transition (home with services vs. SNF for IV antibiotics and PT).

— Prosthetic joint infection requiring revision arthroplasty.

— Pediatric septic hip without pediatric ortho on site.

— Complex multidrug-resistant organisms requiring infectious-disease expertise.

CCS pearl: On CCS, the correct admission order set includes "admit to medicine, telemetry/floor, NPO until OR, IV antibiotics, IVF, DVT prophylaxis, PT/OT consult, orthopedic surgery consult, infectious disease consult, blood cultures, repeat labs in 24 h."

Board pearl: Concurrent S. aureus bacteremia in septic arthritis triggers TTE, repeat blood cultures q48h until clearance, and minimum 4 weeks IV antibiotics — manage as if it were endocarditis until proven otherwise.

All confirmed or strongly suspected septic arthritis warrants admission; outpatient management is inappropriate even for "well-appearing" patients.
Mandatory consultations:
ICU triage criteria:
Stepdown / floor management:
Discharge criteria:
Transfer to tertiary center:
Solid White Background
Key Differentials — Other Inflammatory/Infectious Joint Conditions

Gout: monosodium urate, negatively birefringent needle-shaped crystals; first MTP (podagra), midfoot, knee. Often presents identical to septic — same workup applies.

Pseudogout (CPPD): rhomboid, positively birefringent crystals; knee, wrist; chondrocalcinosis on XR.

Critical caveat: Crystals and infection can coexist in ~5% — Gram stain and culture every tap regardless of crystal result.

— Post-GI (Salmonella, Shigella, Campylobacter, Yersinia) or post-GU (Chlamydia trachomatis) infection.

— Asymmetric oligoarthritis lower extremities, enthesitis, dactylitis, conjunctivitis, urethritis ("can't see, can't pee, can't climb a tree").

— Synovial fluid is inflammatory but sterile; HLA-B27 association.

— Treat with NSAIDs; antibiotics only for active Chlamydia.

— Late disseminated Lyme — recurrent large-joint (knee) effusions, surprisingly well-preserved function.

— Serology with confirmatory immunoblot; synovial PCR.

Doxycycline 100 mg BID ×28 days; refractory → ceftriaxone IV.

— Parvovirus B19, hepatitis B/C, HIV seroconversion, chikungunya — symmetric polyarthritis, often hands/wrists.

— Self-limited; supportive care.

— Indolent monoarthritis in immunocompromised or endemic exposure; AFB and fungal cultures on synovial fluid.

— TB arthritis often hip or knee with adjacent osteomyelitis.

Key distinction: Migratory arthritis differential = rheumatic fever (post-strep, JONES), DGI, Lyme, SBE, SLE — context distinguishes.

Board pearl: A patient with established gout who develops fever + monoarticular flare not responding to colchicine/NSAIDs/steroids deserves a repeat tap to rule out superimposed septic arthritis.

Crystal arthropathies:
Reactive arthritis (ReA):
Lyme arthritis:
Viral arthritis:
Mycobacterial / fungal:
Solid White Background
Key Differentials — Non-Inflammatory and Non-Articular Causes

Cellulitis / erysipelas — erythema and warmth over joint but preserved passive ROM; no effusion on US.

Bursitis (prepatellar, olecranon) — septic vs. aseptic; aspirate the bursa, not the joint; S. aureus most common in septic bursitis.

Tenosynovitis — Kanavel signs in flexor tenosynovitis (fusiform swelling, semi-flexed digit, tenderness along sheath, pain with passive extension) — hand surgery emergency.

Septic flexor tenosynovitis — IV antibiotics + surgical drainage.

Abscess — fluctuant, focal; needs I&D.

Hemarthrosis — anticoagulation, hemophilia, ACL tear; bloody aspirate, low WBC.

Fracture / occult fracture — radiograph, MRI if suspicion high.

Meniscal tear / loose body — mechanical symptoms, no systemic features.

RA flare — polyarticular, symmetric, morning stiffness, anti-CCP/RF positive; risk factor for septic arthritis — keep low threshold to tap.

Spondyloarthropathy — psoriatic arthritis, AS — pattern recognition.

SLE — non-erosive arthritis, multisystem features.

Adult-onset Still's disease — quotidian fevers, salmon rash, ferritin extremely elevated.

DVT — calf swelling, US-confirmed; can mimic knee process.

Avascular necrosis of femoral head — subacute groin pain, history of steroids/EtOH/sickle cell.

Metastatic disease / primary bone tumor — focal bone pain, weight loss, plain film/MRI findings.

PVNS / synovial chondromatosis — chronic monoarticular swelling, MRI shows characteristic findings.

Step 3 management: In an anticoagulated patient with a hot swollen joint, still tap — bloody fluid with low WBC supports hemarthrosis; do not assume without aspiration.

Board pearl: Olecranon bursitis fluid with WBC >2,000–5,000/μL or Gram-positive cocci → septic bursitis; outpatient oral antibiotics often suffice if systemically well.

Periarticular processes mimicking septic joint:
Trauma and mechanical:
Inflammatory systemic disease:
Vascular / oncologic:
Solid White Background
Secondary Prevention, Discharge Medications, and Long-Term Plan

— Most native joint cases: total 3–4 weeks therapy; first 2 weeks IV (longer for S. aureus bacteremia, osteomyelitis, immunocompromised).

— Transition to oral once afebrile, declining CRP, susceptibilities known, reliable oral absorption: high-bioavailability options include levofloxacin, linezolid, TMP-SMX, clindamycin, doxycycline.

— Prosthetic joint with retention: chronic oral suppression (months to lifelong) — typically doxycycline, TMP-SMX, cephalexin, or rifampin combinations (rifampin always paired to prevent resistance).

— Requires reliable patient, home health/infusion services, PICC line, weekly labs (CBC, CMP, CRP, drug levels), ID follow-up.

— Counsel on PICC care, signs of line infection, DVT.

— Endocarditis: 4–6 weeks IV; valve surgery if indicated.

— Dental, skin, GU sources: address definitively (dental clearance, ulcer care, urology workup).

— STI screening (HIV, syphilis, hepatitis B/C) in DGI cases; partner notification and treatment.

— Diabetes optimization (HbA1c <8%), nutritional support, smoking cessation, alcohol reduction.

— Address IV drug use: harm-reduction counseling, MAT (buprenorphine/methadone), naloxone prescription, SW referral.

— Optimize RA control while balancing immunosuppression timing post-infection (hold biologics during active infection; restart after clearance with rheumatology guidance).

— Pneumococcal (PCV20 or PCV15+PPSV23), influenza, COVID-19, RSV per age guidelines — especially in elderly and immunocompromised.

Step 3 management: Before discharge, confirm: antibiotic plan written, OPAT arranged, ID and orthopedic follow-up scheduled within 1–2 weeks, PT plan in place, weekly lab orders sent, primary care notified.

Board pearl: Prophylactic antibiotics before dental procedures in prosthetic joint patients is not routinely recommended by ADA/AAOS — exceptions for high-risk patients only.

Antibiotic completion:
OPAT (outpatient parenteral antibiotic therapy):
Treat underlying source:
Modifiable risk reduction:
Vaccinations:
Solid White Background
Follow-Up, Monitoring Parameters, and Rehabilitation

— Orthopedic surgery: 1–2 weeks post-discharge, then 4–6 weeks, then 3 months.

— Infectious disease: weekly during IV course, then 2 weeks after antibiotic completion.

— Primary care: 1–2 weeks post-discharge for medication reconciliation, comorbidity check.

Weekly CBC, CMP, CRP (and ESR less often).

— Vancomycin AUC or trough q5–7 days when stable; more often with renal change.

— LFTs if on linezolid, rifampin, or hepatotoxic combinations.

— CK weekly on daptomycin.

C. difficile PCR if new diarrhea.

— Plain films at 6 weeks and 3 months to assess for osteomyelitis or joint destruction.

— MRI if persistent pain or markers not normalizing.

— Echo follow-up if endocarditis was diagnosed.

Early passive ROM (within 48–72 h of source control) to prevent contractures.

— Progressive active ROM and strengthening once infection controlled (~1–2 weeks).

— Weight-bearing as tolerated per orthopedic guidance.

— Formal PT/OT referral; consider home PT for elderly or post-op.

— Functional reassessment at 6 weeks and 3 months.

— Warning signs: recurrent fever, increasing pain, new effusion, drainage from incision → immediate return.

— Adherence to full antibiotic course even after symptom resolution.

— Activity modification; gradual return to work/sports based on joint recovery.

— Mental health: chronic pain, depression after prolonged hospitalization, especially in elderly.

Step 3 management: A patient 2 weeks post-discharge with rising CRP, increasing joint pain, and a new effusion → arrange repeat arthrocentesis and orthopedic re-evaluation same day; do not extend antibiotics empirically without re-imaging or re-tapping.

Board pearl: Normalization of CRP is the most reliable single marker of treatment success — persistent elevation at 4 weeks is a red flag for inadequate source control or osteomyelitis.

Clinical follow-up cadence:
Laboratory monitoring during therapy:
Imaging follow-up:
Rehabilitation:
Patient counseling:
Solid White Background
Ethical, Legal, and Patient Safety Considerations

— Document risks (bleeding, infection introduction, neurovascular injury) and alternatives.

— In emergent septic shock, two-physician documentation of implied consent if patient lacks capacity and no surrogate is reachable.

— Decisional capacity assessment for patients refusing tap or drainage — particularly relevant in altered mentation from sepsis or substance use.

Gonococcal infection is reportable to public health in all US jurisdictions; ensure partner notification (Expedited Partner Therapy where legal).

— TB arthritis: reportable.

— IVDU-related infections: not reportable per se, but addiction counseling and referral are standard of care; harm-reduction approach.

— Discharge with PICC and OPAT: leading cause of readmission is line complication or incomplete antibiotic plan. Use structured handoff (e.g., I-PASS) to ID and primary care.

— Medication reconciliation: ensure DVT prophylaxis decision, pain plan with opioid stewardship (PDMP check, naloxone co-prescribing).

— Confirm follow-up appointments are scheduled before discharge, not "patient to call."

— Wrong-site surgery: time-out, joint marking; particularly with bilateral pathology.

— Vancomycin/piperacillin-tazobactam combination AKI — choose alternatives when possible.

— Anticoagulation reversal decisions documented; arthrocentesis can proceed on therapeutic anticoagulation in most cases.

— IVDU stigma may delay diagnosis; treat with same urgency.

— Insurance and OPAT: some patients need SNF placement because home infusion isn't covered — engage social work early.

Step 3 management: Always perform a formal discharge medication reconciliation, confirm follow-up appointments in writing, and use teach-back to verify patient understanding of OPAT protocol — these reduce 30-day readmission, a value-based metric.

Board pearl: A patient with septic arthritis from IVDU who leaves AMA mid-treatment requires capacity assessment, harm reduction counseling, oral antibiotic bridge, and clear documentation — not abandonment.

Informed consent for arthrocentesis and surgery:
Mandatory reporting:
Transitions of care — high-risk handoffs:
Patient safety:
Health equity considerations:
Ethics of antibiotic suppression in PJI: Discuss goals of care when revision is not feasible (frail elderly) — chronic oral suppression vs. resection arthroplasty.
Solid White Background
High-Yield Associations and Rapid-Fire Clinical Facts

S. aureus — most common overall, all ages.

N. gonorrhoeae — sexually active young adults, DGI triad.

Streptococcus pneumoniae — splenectomy, sickle cell, alcoholism.

Salmonella — sickle cell disease.

Pseudomonas aeruginosa — IV drug use, puncture through shoe.

Pasteurella multocida — cat/dog bite.

Eikenella corrodens — human bite, "fight bite."

Capnocytophaga — dog bite in asplenic.

Sporothrix schenckii — rose thorn injury, gardener.

Mycobacterium marinum — fish tank, aquarium.

Brucella — unpasteurized dairy, livestock exposure.

Borrelia burgdorferi — late Lyme, knee.

Kingella kingae — toddlers, fastidious, blood culture bottles.

Cutibacterium acnes — shoulder prosthesis.

— Sternoclavicular / sacroiliac → IV drug use.

— Knee → most common overall.

— Hip → children, intra-abdominal source spread.

— Prosthetic shoulder → C. acnes.

— Hand small joints → DGI or gout flare.

— Synovial WBC >50,000 + >75% PMNs → septic likely.

— Gram stain sensitivity only ~30–50%.

— Synovial glucose <50% serum suggestive but nonspecific.

— CRP > ESR for monitoring response.

— MSSA → cefazolin/nafcillin > vancomycin.

— DGI → ceftriaxone + treat for Chlamydia.

— Lyme arthritis → doxycycline 28 days oral.

— Rifampin combo for staph PJI with retained hardware.

— Cefepime causes encephalopathy in CKD.

Board pearl: "Fever + monoarticular hot joint + crystals present" does not rule out septic arthritis. Always culture.

Key distinction: Migratory polyarthralgia + tenosynovitis + pustules = DGI; abrupt fixed monoarthritis = non-gonococcal S. aureus.

Pathogen ↔ host associations:
Joint ↔ scenario:
Lab pearls:
Therapy pearls:
Solid White Background
Board Question Stem Patterns

— 65-year-old with RA on methotrexate presents with 3-day swollen, hot left knee, fever 38.7°C, refuses to bend knee. Synovial WBC 78,000 with 92% PMNs, Gram stain shows GPCs in clusters.

Answer: Arthrocentesis already done → empiric vancomycin + ceftriaxone, urgent ortho consult for arthroscopic washout.

— 24-year-old sexually active woman with 1-week migratory wrist/ankle pain, vesicopustular rash on fingers, tenosynovitis of right wrist.

Answer: Blood/synovial/urethral NAAT for gonococcus; IV ceftriaxone 1 g daily + single dose azithromycin/doxycycline for Chlamydia; partner notification.

— 32-year-old with IV heroin use, fever, sternoclavicular swelling, tender to palpation.

Answer: CT chest to evaluate mediastinal extension; vancomycin + cefepime; ortho/CT surgery consult; HIV/HCV/HBV testing; addiction medicine referral.

— 3-year-old with fever, refusal to walk, hip held in flexion-abduction-ER; ESR 60, WBC 16,000.

Answer: Kocher 4/4 → urgent OR drainage; cover S. aureus and Kingella with cefazolin or vancomycin.

— 70-year-old 6 months post TKA with 4 weeks of pain, sinus tract drainage. Synovial WBC 4,500 with 70% PMNs, culture-negative.

Answer: Chronic PJI → two-stage revision arthroplasty; hold antibiotics before re-aspiration if safe; consider alpha-defensin and prolonged anaerobic cultures.

— Known gout patient with knee flare, fever, synovial WBC 60,000 with positive crystals and Gram stain showing GPCs.

Answer: Treat both — antibiotics + drainage plus anti-inflammatory for crystals.

Step 3 management: When the stem includes "what is the next best step" in a hot joint scenario, the answer is almost always arthrocentesis unless the patient is in shock — then it's antibiotics + IVF + simultaneous arrangement of tap.

Board pearl: "Polyarticular septic arthritis" stem = check TTE for endocarditis.

Stem 1 — Classic non-gonococcal:
Stem 2 — DGI:
Stem 3 — IVDU:
Stem 4 — Septic hip in toddler:
Stem 5 — Prosthetic knee:
Stem 6 — Crystals + infection:
Solid White Background
One-Line Recap

Septic arthritis is a joint-and-life-threatening emergency in which urgent arthrocentesis, prompt empiric IV antibiotics tailored to host and Gram stain, and definitive surgical drainage — not antibiotics alone — determine outcome.

Board pearl: When in doubt — tap the joint, culture the blood, call ortho, start vanc + ceftriaxone.

Diagnostic rule: Any acutely inflamed monoarticular joint is septic until tap proves otherwise; synovial WBC >50,000 with >75% PMNs + Gram stain/culture + crystal analysis are the diagnostic core, performed before antibiotics whenever hemodynamically feasible.
Empiric therapy rule: Vancomycin covers MRSA; add ceftriaxone for gonococcal or gram-negative concern; cefepime/pip-tazo for IVDU or Pseudomonas risk; switch to cefazolin or nafcillin for confirmed MSSA — these beat vancomycin and are higher-yield Step 3 answers.
Source control rule: Drainage is mandatory — serial aspirations or arthroscopic washout for accessible native joints, open arthrotomy for hip and complex cases, and DAIR vs. 1- or 2-stage revision for prosthetic joints based on chronicity and stability. Failure to improve at 48–72 hours means inadequate source control, not wrong antibiotic.
Step 3 longitudinal rule: Plan 2–4 weeks total antibiotics (6+ weeks if osteomyelitis), arrange OPAT with weekly labs and ID/orthopedic follow-up, address the source (endocarditis, STI, IVDU, dental, diabetes), and document patient-safety checkpoints — medication reconciliation, scheduled appointments, teach-back, and early PT — before discharge to prevent the readmission, chronic dysfunction, and mortality that define this disease's morbidity profile.
Solid White Background
bottom of page